Dr. Minnie Sarwal Profiled as Innovator in the Targeted Management of Kidney Transplants
International Innovation, an online forum for the communication and dissemination of cutting-edge research, recently reported on the pioneering efforts of the Sarwal Lab to develop novel translational approaches for improving the management of kidney transplant patients and treating renal disease. The article reports on the lab's breakthrough assays, the kidney solid organ rejection test (kSORT) and the kidney spontaneous operational tolerance test (kSPOT), and their potential to revolutionize the way kidney transplant patients are managed after transplantation by predicting acute rejection.
For those with organ failure or severe disease, organ transplantation can offer a new lease of life that would otherwise be impossible. Kidneys are the most common candidate organs for transplantation in the US, but there are still a number of ways in which scientists are looking to improve the procedure.
One such scientist is Dr. Minnie Sarwal, who has dedicated her career to developing a personalised approach to organ transplantation and overseeing the translation of these efforts into clinical practice. She leads a dedicated team of researchers at the University of California, San Francisco, where they are making use of high-throughput technologies to develop assays that will ultimately lead to reduced morbidity and improved quality of life...................